Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM50011716 (CHEMBL3262896) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research Curated by ChEMBL | Assay Description Antagonist activity at EBI2 receptor in human U937 cells assessed as inhibition of 7-alpha,25-OHC-induced cell migration after 3 hrs by flow cytometr... | J Med Chem 57: 3358-68 (2014) Article DOI: 10.1021/jm4019355 BindingDB Entry DOI: 10.7270/Q2BG2QJ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM50011701 (CHEMBL3262895) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research Curated by ChEMBL | Assay Description Antagonist activity at recombinant human EBI2 receptor expressed in CHO cells assessed as inhibition of NIBR51-induced intracellular calcium release ... | J Med Chem 57: 3358-68 (2014) Article DOI: 10.1021/jm4019355 BindingDB Entry DOI: 10.7270/Q2BG2QJ5 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332588 (4-({2-[(2E)-3-(4-bromophenyl)prop-2-enoyl]-2,7-dia...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332648 ((2E)-3-(4-bromophenyl)-1-{2-[(4-chlorophenyl)carbo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332646 (5-bromoindol-2-yl 7-{[4-(trifluoromethyl)phenyl]ca...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332645 (5-chloroindol-2-yl 9-{[3-fluoro-4-(trifluoromethyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332641 (3-(4-fluorophenyl)-1-(7-{[4-(trifluoromethyl)pheny...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332640 (1-{7-[(4-bromophenyl)carbonyl]-2,7-diazaspiro[3.5]...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332546 ((2E)-1-{7-[(2E)-3-(4-bromophenyl)prop-2-enoyl]-2,7...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332547 ((2E)-3-(4-bromophenyl)-1-{7-[(3-bromophenyl)carbon...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332549 (5-chloroindol-2-yl 2-[(3-fluorophenyl)methyl]-2,7-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332551 ((2E)-3-(4-bromophenyl)-1-{2-[(4-chlorophenyl)methy...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332552 ((2E)-3-(4-bromophenyl)-1-[2-(phenylcarbonyl)-2,7-d...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332553 ((2E)-3-(4-bromophenyl)-1-{2-[(4-fluorophenyl)methy...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332554 ((2E)-1-{2-[(3,4-dimethoxyphenyl)carbonyl]-2,7-diaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332555 ((2E)-1-{2-[(3,5-dichlorophenyl)carbonyl]-2,7-diaza...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332556 ((2E)-1-{2-[(2,6-dichlorophenyl)methyl]-2,7-diazasp...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332557 ((2E)-3-(4-bromophenyl)-1-{2-[(3-methylphenyl)carbo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332562 (5-chloroindol-2-yl 2-[(4-fluorophenyl)methyl]-2,7-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332563 (5-chloroindol-2-yl 7-{[3-fluoro-4-(trifluoromethyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332564 ((2E)-3-(4-bromophenyl)-1-{7-[(4-chlorophenyl)carbo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332565 ((2E)-3-(4-bromophenyl)-1-{7-[(4-fluorophenyl)carbo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332566 ((2E)-3-(4-bromophenyl)-1-(7-{[4-(trifluoromethyl)p...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332567 ((2E)-3-(4-bromophenyl)-1-(7-{[4-fluoro-3-(trifluor...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332573 ((2E)-3-(3,4-dichlorophenyl)-1-{7-[(4-fluorophenyl)...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332574 ((2E)-3-(3,4-dichlorophenyl)-1-{7-[(4-chlorophenyl)...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332575 ((2E)-3-(3,4-dichlorophenyl)-1-(7-{[4-(trifluoromet...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332580 ((2E)-1-{2-[(2E)-3-(3,4-dichlorophenyl)prop-2-enoyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332584 (5-chloroindol-2-yl 7-{[4-(trifluoromethyl)phenyl]c...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332585 (5-chloroindol-2-yl 7-[(4-chlorophenyl)carbonyl]-2,...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332550 (5-chloroindol-2-yl 2-[(4-fluorophenyl)carbonyl]-2,...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332589 ((2E)-1-{7-[(3,5-difluorophenyl)carbonyl]-2,7-diaza...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332590 ((2E)-3-(4-bromophenyl)-1-(7-{[4-fluoro-2-(trifluor...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332591 (5-bromoindol-2-yl 7-[(4-bromophenyl)carbonyl]-2,7-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332593 (5-bromoindol-2-yl 7-{[4-fluoro-2-(trifluoromethyl)...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332596 ((2E)-1-{7-[(4-aminophenyl)carbonyl]-2,7-diazaspiro...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332597 ((2E)-3-(4-bromophenyl)-1-(2-{[4-fluoro-2-(trifluor...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332598 ((2E)-3-(4-bromophenyl)-1-{2-[(4-fluorophenyl)carbo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332599 ((2E)-3-(4-bromophenyl)-1-(2-{[4-(trifluoromethyl)p...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332613 (3-(4-bromophenyl)-1-{2-[(4-fluorophenyl)methyl]-2,...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332614 (3-(4-bromophenyl)-1-{2-[(4-chlorophenyl)methyl]-2,...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332616 (3-(4-bromophenyl)-1-(2-{[4-(trifluoromethyl)phenyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332617 (3-(4-bromophenyl)-1-{2-[(4-bromophenyl)methyl]-2,7...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332618 (3-(4-bromophenyl)-1-(2-{[4-(trifluoromethyl)phenyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332619 (3-(4-bromophenyl)-1-{2-[(4-methoxyphenyl)carbonyl]...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332621 (3-(4-chlorophenyl)-1-{2-[(4-chlorophenyl)carbonyl]...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332622 (3-(4-chlorophenyl)-1-{2-[(4-fluorophenyl)carbonyl]...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332623 (3-(4-chlorophenyl)-1-(2-{[4-(trifluoromethyl)pheny...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332624 (3-(4-chlorophenyl)-1-(2-{[4-(trifluoromethyl)pheny...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
G-protein coupled receptor 183 (Homo sapiens (Human)) | BDBM332625 (3-(4-chlorophenyl)-1-(7-{[4-(trifluoromethyl)pheny...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5 | n/a | n/a | n/a | n/a | n/a | n/a |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE US Patent | Assay Description The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali... | US Patent US10196369 (2019) BindingDB Entry DOI: 10.7270/Q2BR8V88 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 167 total ) | Next | Last >> |